GovWire

Spreadex / Sporting Index merger inquiry

Competition Markets Authority

February 13
15:00 2025

class="gem-c-govspeak govuk-govspeak govuk-!-margin-bottom-0">

Phase 2

Administrative timetable

Referral date: 17 April 2024

Statutory deadline: 4 December 2024

Contact

Email: SpreadEx.SportingIndex@cma.gov.uk

Notice of extension of statutory period to accept final undertakings

13 February 2025: The CMA has extended the statutory period to accept final undertakings. The extended period will therefore end on 28 March 2025.

Notice of proposal to accept final undertakings

16 January 2025: The CMA gives notice of the proposal to accept final undertakings and is inviting comments on the proposed draft undertakings by 5pm on 31 January 2025.

Final report

22 November 2024: The CMA has published its final report.

Notice of extension of statutory period

Responses to the provisional findings

Responses to the notice of possible remedies

Notice of extension of statutory period

Provisional findings

25 July 2024: The CMA has provisionally found competition concerns as part of its in-depth investigation of the completed acquisition by Spreadex Limited of the B2C business of Sporting Index Limited.

The deadline for submitting responses to the notice of possible remedies is 8 August 2024. The deadline for submitting responses to the provisional findings is 15 August 2024.

Directions to appoint a monitoring trustee

11 July 2024: On 29 April 2024, pursuant to an initial enforcement order dated 15 January 2024, the CMA directed Spreadex.Com Limited and Spreadex Limited to appoint a monitoring trustee.

Issues statement

16 May 2024: The issues statement sets out the scope of the inquiry. It outlines initial theories on what might be adversely affecting competition, but it does not set out findings or conclusions. The deadline for submissions on the issues statement is 5pm, 29 May 2024.

Inquiry group appointed

17 April 2024: The CMA has appointed the inquiry group:

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: